X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (579) 579
humans (534) 534
anticoagulation (499) 499
male (307) 307
female (290) 290
anticoagulants (259) 259
aged (244) 244
middle aged (217) 217
warfarin (209) 209
anticoagulants - therapeutic use (184) 184
risk factors (165) 165
thromboembolism (150) 150
atrial fibrillation (141) 141
oral anticoagulation (137) 137
anticoagulants - administration & dosage (135) 135
hematology (134) 134
anticoagulants - adverse effects (131) 131
peripheral vascular disease (131) 131
adult (129) 129
cardiac & cardiovascular systems (128) 128
thrombosis (127) 127
stroke (124) 124
therapy (122) 122
management (121) 121
aged, 80 and over (111) 111
surgery (110) 110
risk (107) 107
care and treatment (102) 102
retrospective studies (91) 91
medicine & public health (89) 89
treatment outcome (89) 89
prevention (83) 83
aspirin (81) 81
analysis (79) 79
abridged index medicus (78) 78
venous thromboembolism (77) 77
warfarin - therapeutic use (74) 74
prospective studies (73) 73
administration, oral (70) 70
medicine, general & internal (69) 69
drug therapy (66) 66
mortality (66) 66
risk-factors (66) 66
recurrence (65) 65
international normalized ratio (64) 64
time factors (64) 64
atrial-fibrillation (62) 62
complications (61) 61
molecular-weight heparin (61) 61
atrial fibrillation - drug therapy (60) 60
heparin (60) 60
warfarin - administration & dosage (60) 60
hemorrhage (59) 59
pharmacology & pharmacy (57) 57
warfarin - adverse effects (57) 57
follow-up studies (56) 56
platelet aggregation inhibitors - therapeutic use (55) 55
bleeding (54) 54
antithrombotic therapy (52) 52
patients (52) 52
health aspects (51) 51
hemorrhage - chemically induced (50) 50
internal medicine (50) 50
stroke - prevention & control (50) 50
cardiac arrhythmia (48) 48
incidence (47) 47
thromboembolism - prevention & control (47) 47
cardiology (46) 46
deep-vein thrombosis (45) 45
risk assessment (44) 44
atrial fibrillation - complications (41) 41
research (41) 41
coagulation (40) 40
complications and side effects (40) 40
d-dimer (39) 39
fibrinolytic agents - therapeutic use (39) 39
medical research (39) 39
pulmonary-embolism (39) 39
cardiovascular (38) 38
clinical trials (38) 38
dabigatran (38) 38
clinical neurology (37) 37
cohort studies (37) 37
dosage and administration (37) 37
metaanalysis (37) 37
pulmonary embolism (37) 37
safety (37) 37
vitamin k - antagonists & inhibitors (37) 37
antiplatelet therapy (36) 36
diagnosis (36) 36
medicine, experimental (34) 34
stroke prevention (32) 32
thrombin (31) 31
young adult (31) 31
adolescent (30) 30
aspirin - therapeutic use (30) 30
blood coagulation - drug effects (30) 30
drug therapy, combination (30) 30
usage (30) 30
prognosis (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (741) 741
German (13) 13
French (9) 9
Portuguese (4) 4
Spanish (3) 3
Dutch (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FRONTIERS IN NEUROLOGY, ISSN 1664-2295, 12/2018, Volume 9, pp. 1095 - 1095
Introduction: Discontinuation of oral anticoagulants such as non-vitamin K antagonist oral anticoagulants (NOACs) may induce a hypercoagulable state, leading... 
THROMBIN | TRANSIENT ISCHEMIC ATTACK | anticoagulation | RIVAROXABAN | PREVENTION | stroke | NEUROSCIENCES | non-valvular atrial fibrillation | cardiac embolism | ADHERENCE | CLINICAL NEUROLOGY | THERAPY | WARFARIN | THROMBOEMBOLISM | NONVALVULAR ATRIAL-FIBRILLATION | ASSOCIATION | outcome | Stroke (Disease) | Anticoagulants (Medicine) | Analysis | Risk factors
Journal Article
La Presse Médicale, ISSN 0755-4982, 05/2017, Volume 46, Issue 5, pp. e77 - e83
Deep vein thrombosis (DVT) is a potential serious common disease. Its management is, except in particular cases, on an outpatient basis. General practitioner's... 
MEDICINE, GENERAL & INTERNAL | RECURRENT VENOUS THROMBOEMBOLISM | MANAGEMENT | ORAL ANTICOAGULATION | VTE | PULMONARY-EMBOLISM | ANTITHROMBOTIC THERAPY | GUIDELINES | DISEASE | PREVENTION | CANCER
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 10/2014, Volume 111, Issue 1, pp. 172 - 179
Journal Article
ARQUIVOS DE NEURO-PSIQUIATRIA, ISSN 0004-282X, 07/2019, Volume 77, Issue 7, pp. 456 - 459
Patients on anticoagulant or antiplatelet therapy are often required to discontinue these medications before and during surgical or invasive procedures. In... 
Stroke | PSYCHIATRY | RISK | HEPARIN | ASPIRIN | NEUROSCIENCES | ATRIAL-FIBRILLATION PATIENTS | DISCONTINUATION | ANTICOAGULATION | ischemic attack, transient | THERAPY | compliance | anticoagulants | WITHDRAWAL | Anticoagulants | Warfarin | Transient ischemic attack | Ischemia | Surgery | Antagonists | Patients | Hemorrhage | Risk factors | Vitamin K | Index Medicus
Journal Article
Journal Article